Experience of the clinical application of dialysis for long term replacement of renal function now extends for two decades. The first decade was in general devoted to improving the design of existing equipment to make it safe and suitable for routine use, and the second to conceiving new ideas. However, so far most of the new ideas have found little routine clinical application and the old methods remain in general use although transformed by new industrial techniques to give greater efficiency.
IMPROVING BASIC CONCEPTS

Blood access
In an excellent historical review of dialysis' it can be seen that blood access is the Achilles' tendon of long term haemodialysis. The initial breakthrough came with the development of the Quinton-Scribner external arteriovenous shunt.2 Unfortunately its use was complicated by infections and by clotting, resulting in eventual loss of access. The next and most valuable improvement came with the concept of the internal arteriovenous fistula, which when well fashioned and efficiently used gives permanent access. There are certain patients, some even before starting dialysis treatment, who have lost major veins through thrombosis, and these can be provided with bridged arteriovenous fistulae based on homologous3 or bovine heterologous vein grafts,4 5 and more recently on mandril-grown autografts6 or polytetra-fluoroethylene(PTFE) self-sealingconduits.
Dialysers
The desire to improve dialysers is as keen today as it was 20 years ago. Originally the aim was for efficiency and low resistance, small blood volume and easy reassembly without technical failure or rupture of membranes. Today it is taken for granted that rupture of membranes will not occur; that the dialyser will be extremely small but will The new concepts discussed above have neither simplified the treatment nor reduced the cost and unless it can be proved that the patients treated by the new methods have substantial clinical advantages there is no great incentive to use them routinely.
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS-CAPD
There is, however, one new concept which has simplified treatment and reduced cost, and this has occurred in the field of peritoneal dialysis. It is termed Continuous Ambulatory Peritoneal Dialysis or CAPD, the original method of intermittent peritoneal dialysis now being termed IPD.
The improvement and simplification of peritoneal dialysis came about by a very logical approach to the characteristics of peritoneal dialysis. Peritoneal dialysis has only 1/6th the efficiency of haemodialysis of similar duration, because the dialysate does not achieve anything like full equilibration with the patient's blood during the 10-40 minutes normally allowed for dwell in the peritoneal cavity; 6-8 hours is a more realistic equilibration period. Attempts to improve efficiency by the use of drugs to increase peritoneal blood flow or permeability of the peritoneal membrane have had little success. Increasing the flow rate of dialysis fluid achieves only a slight increase in efficiency because the dialysate becomes even less equilibrated, and the cost of dialysis fluid is greatly increased for little gain. Hence the best way to increase efficiency is to prolong the period of equilibration between dialysate and blood, and this makes it possible to reduce the volume of dialysis fluid. This is the basis of CAPD.
Standard Baillod eliminated, patients do extremely well. This observation makes it apparent that although the treatment is simple it cannot be safely applied to all patients, as some are so poorly disciplined that patient error is inevitable and peritonitis and morbidity are frequent with eventual loss of effective peritoneal membrane. Hence, although this treatment has been in use for only four years, there has been a steady loss of patients from CAPD to haemodialysis and transplant. Technical improvements will occur and the failure rate will fall-but the final judgement of this treatment must be reserved.
